Evidence map›Paper›PMID 31366080›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Nanophosphor-Based Contrast Agents for Spectral X-ray Imaging.

Kevin Smith, Matthew Getzin, Josephine J Garfield, Sanika Suvarnapathaki, Gulden Camci-Unal, Ge Wang, Manos Gkikas

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. ZnWONanomaterials (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kevin SmithDepartment of Chemistry, University of Massachusetts Lowell, Lowell, MA 01854, USA.
Matthew GetzinDepartment of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Josephine J GarfieldDepartment of Chemistry, University of Massachusetts Lowell, Lowell, MA 01854, USA.
Sanika SuvarnapathakiBiomedical Engineering and Biotechnology Program, University of Massachusetts Lowell, Lowell, MA 01854, USA.
Gulden Camci-UnalDepartment of Chemical Engineering, University of Massachusetts Lowell, Lowell, MA 01854, USA.
Ge WangDepartment of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY 12180, USA. wangg6@rpi.edu.ORCID 0000-0002-2656-7705
Manos GkikasDepartment of Chemistry, University of Massachusetts Lowell, Lowell, MA 01854, USA. manos_gkikas@uml.edu.

Funding

National Institutes of Health S10RR027897National Institutes of Health U01 EB017140
6 · The paper itself

Abstract

Lanthanide-based nanophosphors (NPhs) are herein developed as contrast agents for spectral X-ray imaging, highlighting the chemical, macromolecular and structural differences derived from ligand exchange on computed tomography (CT) and solvent dispersibility. Taking advantage of the ability of spectral X-ray imaging with photon-counting detectors to perform image acquisition, analysis, and processing at different energy windows (bins), enhanced signal of our K-edge materials was derived, improving sensitivity of CT imaging, and differentiation between water, tumor-mimic phantoms, and contrast materials. Our results indicate that the most effective of our oleic acid-stabilized K-edge nanoparticles can achieve 2-4x higher contrast than the examined iodinated molecules, making them suitable for deep tissue imaging of tissues or tumors. On the other hand, ligand exchange yielding poly(acrylic acid)-stabilized K-edge nanoparticles allows for high dispersibility and homogeneity in water, but with a lower contrast due to the high density of the polymer grafted, unless further engineering is probed. This is the first well-defined study that manages to correlate NPh grafting density with CT numbers and water dispersibility, laying the groundwork for the development of the next generation CT-guided diagnostic and/or theranostic materials.

Indexed as

computed tomographyCT imaginglanthanide nanoparticlesnanophosphorsrare earth metalsspectral CTX-ray contrast agents

Identifiers

PMID31366080
PMCPMC6723483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.